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The diagnosis of disseminated intravascular
coagulation (DIC) based on composite scoring
systems using routinely available coagulation tests has
been greatly facilitated. Such scoring instruments not
only adequately assess the presence of DIC but also
have strong prognostic power for morbidity and
mortality. In this issue of Critical Care, Gando and
colleagues report on the prospective validation of the
Japanese Association of Acute Medicine score for DIC
in patients with severe sepsis.tions to ameliorate the coagulation status.
It is interesting to compare the utility of this scoringDisseminated intravascular coagulation (DIC) is a ser-
ious condition with significant morbidity (that is, organ
dysfunction due to microvascular thrombosis, thrombo-
embolic complications and profuse bleeding) and is an
independent predictor of mortality in critically ill pa-
tients. Despite this serious clinical presentation, an ad-
equate diagnosis of DIC is hampered by the limited
availability of one simple and reliable test with sufficient
diagnostic accuracy. However, combinations of several
routinely available coagulation tests may be helpful to
establish this diagnosis.
Many years ago, Japanese investigators were the first
to develop a DIC scoring system, employing readily
available tests such as the platelet count and routine
clotting times. Recently this Japanese scoring system was
updated by the Japanese Association for Acute Medicine
(JAAM). In this issue of Critical Care, Gando and col-
leagues have prospectively validated this renewed Japa-
nese score in 624 patients with severe sepsis [1]. The
authors were able to show the feasibility of the new
JAAM score for DIC and its prognostic power forCorrespondence: m.m.levi@amc.uva.nl
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© 2013 BioMed Central Ltd.multiple organ dysfunction and mortality. In fact, 63% of
nonsurviving patients were classified as having DIC
according to the scoring system in comparison with 42%
of sepsis survivors in this study. Interestingly, the inves-
tigators were able to convincingly show that persistent
DIC was an even worse prognostic indicator for organ
dysfunction and mortality compared with patients in
whom the DIC rapidly resolved. In conclusion, the
renewed JAAM scoring system for DIC seems to be a
valuable tool for clinicians to diagnose patients with
DIC, which can be helpful to identify patients at high
risk and to select patients for supportive treatment op-
system with other DIC scoring algorithms. In 2001 a
simple scoring system was developed by the subcommit-
tee on DIC of the International Society on Thrombosis
and Haemostasis (ISTH) [2]. The score can also be cal-
culated based on routinely available laboratory tests; that
is, platelet count, prothrombin time, a fibrin-related
marker (usually D-dimer), and fibrinogen. A recent
study showed that the International Normalization Ratio
can be used (instead of prothrombin time prolongation),
further facilitating international exchange and
standardization [3]. Prospective studies showed that the
sensitivity of the DIC score was 93% and the specificity
was 98% [4,5]. Studies in series of patients with specific
underlying disorders causing DIC (for example, cancer
patients or patients with obstetric complications) show
similar results [6,7]. The severity of DIC according to
this scoring system was also related to the mortality in
patients with sepsis [8].
When comparing the new JAAM scoring system with
the ISTH score, it seems the JAAM scoring system was
more sensitive than the ISTH score. Interestingly, this
higher sensitivity did not lead to a lower specificity, and
patients who were negative on the ISTH score but who
had DIC according to the new JAAM score had a rela-
tively high mortality. Hence, the JAAM scoring system
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although a formal head-to-head comparison is not
available at present.
It is tempting to speculate how the diagnosis of DIC
may be further improved. DIC is a complication of many
disorders that are associated with a systemic inflammatory
response [9]. Any form of systemic inflammation will vir-
tually always be associated with activation of coagulation,
ranging from changes in molecular markers in coagulation
factors with equivocal clinical significance to its most
full-blown variant, DIC [10]. Interesting to note is that
whereas the hallmark of DIC is activation of coagulation,
our diagnostic tests are mostly centered on assays that
detect consumption of platelets and coagulation factors. If
we want to further improve the diagnosis of DIC, one may
hypothesize that tests which will directly assess coagula-
tion activation in vivo will be helpful. Recently, a renewed
interest in point-of-care tests to assess an overall picture
of coagulation has been raised. Hypercoagulability as
demonstrated with thromboelastography was shown to
correlate with clinically relevant morbidity and mortality
in several studies [11,12], although its superiority over
conventional tests has not yet unequivocally been
established [13].
In conclusion, the renewed JAAM scoring system for
DIC appears to be a valid test for diagnosing DIC in
patients with sepsis and may be helpful in specifically
tailored management strategies in these patients [14]. A
diagnosis of DIC with this new scoring system is a strong
predictor for an adverse outcome. Further improvement
in the diagnosis of DIC may rely on better tests to assess
hypercoagulability, preferably as point-of-care tools.
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